|
|
![]() | ![]() | ![]() | ![]() |
| |||||||||
Legend: (diff) = difference with preceding revision, (hist) = view history for only this reason, m = minor edit, N = new reason.
| (diff) | (hist) | 18:13, June 13, 2008 | Danieljones (Talk | contribs) | N | (→"Company is paying down its debt from the Guidant acquisition, improving balance sheet and margins") | |||||
| (diff) | (hist) | 14:51, April 8, 2008 | Wikinvest MaintenanceBot (Talk | contribs) | m | (Stock:Boston Scientific (BSX)/Bulls/"Company is paying down its debt from the Guidant acquisition, improving balance sheet and margins" moved to [[Stock:Boston Scientific (BSX)/Bulls/Company is paying down its debt from the Guidant acquisition, improv) | |||||
| (diff) | (hist) | 01:24, April 4, 2008 | Uraguck (Talk | contribs) | N | (→Great handling of externalities) | |||||
| (diff) | (hist) | 01:24, April 4, 2008 | Uraguck (Talk | contribs) | N | (→Diversification) | |||||
| (diff) | (hist) | 01:24, April 4, 2008 | Uraguck (Talk | contribs) | N | (→Innovation) | |||||
| (diff) | (hist) | 01:24, April 4, 2008 | Danieljones (Talk | contribs) | N | (→"Company is paying down its debt from the Guidant acquisition, improving balance sheet and margins") | |||||
| (diff) | (hist) | 01:24, April 4, 2008 | Danieljones (Talk | contribs) | N | (→Liberte stent is a big opportunity) |
| |||||||